Antibiotic use in pregnancy and lactation

AN Rui-fang,GOU Wen-li

2012-01-01

Abstract:Pregnancy and lactation period are special physiological periods.Antibiotics are among the most commonly prescribed medications for pregnant and lactating women.In order to protect the health of mothers and infants,we should rationally choose those antibiotics that can control infection effectively and without harm to the embryo,the fetus and the newborn.

What problem does this paper attempt to address?

Antibiotic Therapy in Pregnancy and Lactation

A Reali,A Ximenes,L Cuzzolin,V Fanos,A. Reali,A. Ximenes,L. Cuzzolin,V. Fanos

DOI: https://doi.org/10.1179/joc.2005.17.2.123

2005-04-01

Journal of Chemotherapy

Abstract:When considering whether to administer drugs to women during pregnancy and lactation, we have to take into account that these substances may expose the fetus or neonate to multiple effects. This occurs because there is a unique situation where the maternal compartment is connected with the fetal or neonatal compartment through, respectively, the placental barrier or breast milk. The fetus in utero and the breast-fed neonate are to be considered as organisms exposed and sensitive to the effects of drugs that cross the placenta or enter the breast milk. This review focuses on the most frequently used antibiotics during pregnancy and lactation and presents useful suggestions for daily practice. Drugs that must be avoided are clearly underlined.

oncology,pharmacology & pharmacy,infectious diseases
Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration

Ioannis Mylonas

DOI: https://doi.org/10.1007/s00404-010-1646-3

2010-09-03

Archives of Gynecology and Obstetrics

Abstract:BackgroundInfections during gestation, delivery and the postnatal period can jeopardise not only the mother, but also the child. Along with chromosomal abnormalities and immunological diseases, infection in early pregnancy represents the most important reason for abortion. During the second and third trimester, infections are the principal cause for preterm labour, premature membrane rupture, premature delivery and the resultant complications in the newborn child. Many pregnant women are very cautious about taking antibiotics due to primarily potentially detrimental effects on the unborn child. However, there are no contraindications for antibiotic treatment during pregnancy in the event of a serious infectious disease of the mother.Materials and methodsIn this review the indications and contraindications of the administration of antibiotics during pregnancy are being reviewed.ResultsPenicillins are a first-line antibiotic treatment during pregnancy, with the exception of cases in which there is a maternal allergy to penicillin. Cephalosporins are another first-line antibiotic used during pregnancy. In principle, more commonly used cephalosporins should be given priority. Owing to associated nephrotoxicity and ototoxicity, aminoglycosides should not be prescribed at any time during pregnancy. Systematic use of aminoglycosides should be considered solely in the event of life-threatening infections with gram-negative pathogens and/or treatment failure of recommended antibiotics during pregnancy. The use of metronidazole is also permitted during pregnancy, provided the indications for its use have been strictly verified. Lincosamides should be used only if penicillins, cephalosporins and erythromycin have failed to eradicate infection. Sulfonamides, trimethoprim and cotrimoxazole are second-line agents for the use during pregnancy. Tetracyclines should not be administered to pregnant women after the fifth week of pregnancy, and are deemed contraindicated. As a precautionary measure, gyrase inhibitors are also contraindicated for pregnant women, children and young adolescents.ConclusionOn the basis of our current state of knowledge, the vast majority of antibiotics do not cause serious harm to the unborn child if used properly and at the appropriate doses during pregnancy. The treatment with an antibiotic that is contraindicated does not justify termination of pregnancy. However, ultimately no medicine, including antibiotics, can be described as absolutely safe.

obstetrics & gynecology
Antibiotics and Other Anti-infective Agents in Pregnancy and Lactation

Jennifer R Niebyl

DOI: https://doi.org/10.1055/s-2003-45391

2003-01-01

American Journal of Perinatology

Abstract:Serum levels of many drugs are lower in pregnancy compared with the nonpregnant state. Their renal clearance is higher and the maternal intravascular volume is expanded. Most antibiotics are safe for use in pregnancy and lactation. Tetracyclines cause fetal tooth discoloration and inhibition of bone growth if used in the second and third trimesters. Aminoglycosides carry a small risk of fetal ototoxicity. Quinolones may cause arthropathies in children, and so are currently not recommended for use in pregnancy. Most drugs are secreted into breast milk in very small amounts, not enough to have any therapeutic effect. The only antibiotics which may be of concern in nursing infants are sulfonamides and quinolones, and possibly metronidazole.

pediatrics,obstetrics & gynecology
Antibiotic use in pregnancy

J S Dashe,L C Gilstrap 3rd

DOI: https://doi.org/10.1016/s0889-8545(05)70326-0

Abstract:With a few notable exceptions, most antibiotics can be used with relative safety during pregnancy. Moreover, none of the antibiotics to date has been shown to be teratogenic, although tetracycline may cause yellow-brown discoloration of the deciduous teeth (a fetal effect). Thus, antibiotics should not be withheld from the pregnant woman, especially when indicated for serious, life-threatening infections.
ANTIBACTERIAL AGENTS IN PREGNANCY

Oksana M. Korzeniowski

DOI: https://doi.org/10.1016/s0891-5520(20)30690-5

IF: 5.905

1995-09-01

Infectious Disease Clinics of North America

Abstract:Except for topical, nonabsorbable agents, any antibiotic chosen for use in pregnancy exposes the fetus as well as the mother to its effects. Therefore, initiation of antimicrobial therapy must be based on clear-cut necessity. Because the physiology of the maternal-fetal unit is complex and ethical consideration of potential fetal harm is pre-eminent, data on safety are derived from animal studies, incidental observations on individual women treated with an agent, or longitudinal tracing of groups of women who required treatment with a particular antimicrobial regimen. Consequently, a rating of absolute safety in pregnancy has never been assigned to any currently available antimicrobial agent. Decades of clinical experience with penicillins, cephalosporins, and erythromycins have documented the pharmacokinetics of these drugs in pregnant women as well as their overall safety for the fetus. These classes of drugs are those most favored for use in pregnancy for susceptible infections. Although aminoglycosides have known toxic effects on the fetus, they are safe to use if serum levels are carefully monitored in the mother. Agents in the quinolone, sulfonamide, and tetracycline categories should be avoided unless maternal necessity for their use justifies the exposure of the fetus to their toxicity. Both clinical and experimental data are very limited on the newer agents, such as the new macrolides, azithromycin and clarithromycin. The first-line agents for the treatment of TB (i.e., INH, rifampin, and ethambutol) are considered safe in pregnancy, but in the era of multidrug-resistant mycobacterial isolates, agents with known or suspected fetal toxicity may need to be used.

immunology,infectious diseases
Use of Anti-Infective Agents During Lactation: Part 1—Beta-Lactam Antibiotics, Vancomycin, Quinupristin-Dalfopristin, and Linezolid

Karen G. Chin,Christina Mactal-Haaf,Charles E. McPherson

DOI: https://doi.org/10.1177/089033440001600413

2000-11-01

Journal of Human Lactation

Abstract:Because many antibiotics are excreted into the breast milk, it can be difficult for a practitioner to choose an antibiotic for a lactating patient that will have minimal risks to her nursing infant. This article is the first of a three-part series discussing the use of anti-infective agents during lactation. The authors review general information regarding use and common side effects of several classes of antibiotics. They also summarize information, including documented milk concentrations, milk-to-plasma ratios, and other pharmacokinetic properties, in a table that can help practitioners choose antibiotics that may be considered safe for the lactating mother.

nursing,pediatrics,obstetrics & gynecology
Safety of Anti-hepatitis B Virus Therapy During Pregnancy and Lactation

Dongli SUN,Caihong ZHENG

DOI: https://doi.org/10.13748/j.cnki.issn1007-7693.2017.11.029

2017-01-01

Abstract:Hepatitis B virus (HBV) infection is a worldwide epidemic,while the mother-to-child transmission is the main route of transmission of HBV infection in China.Women of childbearing age often faced with antiviral therapy problem during pregnancy and lactation.Through the retrieval of domestic and foreign database literature,all the approved drugs for anti-hepatitis B virus infection (including interferon α,lamivudine,telbivudine,tenofovir dipivoxil,entecavir,adefovir dipivoxil And enquitril) in pregnancy and lactation using safety data and experience were summarized,and presented by placental transport,animal reproductive toxicity and teratogenicity studies,experience of using in human pregnancy,drug milk secretion and experience of using in human lactation.Among them,research data of tenofovir and telbivudine is relatively sufficient and can be used as a choice of anti-HBV treatment during pregnancy.No teratogenic of both is found in animal studies,and the incidence of birth defects is not increased while tenofovir and telbivudine were employed in human pregnancy.Lamivudine is widely used during pregnancy in human (HIV treatment),and no increase in the incidence of birth defects,it may also be used as one of the options for anti-HBV treatment during pregnancy.
Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation

Yao Yao,Xiaoyu Cai,Weidong Fei,Fujia Ren,Fengmei Wang,Xiaofei Luan,Fengying Chen,Caihong Zheng

DOI: https://doi.org/10.3389/fphar.2020.594042

IF: 5.6

2020-01-01

Frontiers in Pharmacology

Abstract:Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and bone destruction. Microbial infection is considered to be the most important inducement of RA. The pregnancy planning of women in childbearing age is seriously affected by the disease activity of RA. Gut microbiome, related to immunity and inflammatory response of the host. At present, emerging evidence suggested there are significant differences in the diversity and abundance of gut microbiome during pregnancy and lactation, which may be associated with the fluctuation of RA disease activity. Based on these research foundations, we pioneer the idea of regulating gut microbiome for the treatment of RA during pregnancy and lactation. In this review, we mainly introduce the potential treatment strategies for controlling the disease activity of RA based on gut microbiome during pregnancy and lactation. Besides, we also briefly generalize the effects of conventional anti-rheumatic drugs on gut microbiome, the effects of metabolic changes during pregnancy on gut microbiome, alteration of gut microbiome during pregnancy and lactation, and the effects of anti-rheumatic drugs commonly used during pregnancy and lactation on gut microbiome. These will provide a clear knowledge framework for researchers in immune-related diseases during pregnancy. Regulating gut microbiome may be a potential and effective treatment to control the disease activity of RA during pregnancy and lactation.
Antibiotic Prescriptions among China Ambulatory Care Visits of Pregnant Women: A Nationwide Cross-Sectional Study.

Houyu Zhao,Mei Zhang,Jiaming Bian,Siyan Zhan

DOI: https://doi.org/10.3390/antibiotics10050601

2021-01-01

Abstract:BACKGROUND:Antibiotic use in pregnant women at the national level has rarely been reported in China. OBJECTIVES:We aimed to investigate antibiotic prescriptions during pregnancy in ambulatory care settings in China. METHODS:Data of 4,574,961 ambulatory care visits of pregnant women from October 2014 to April 2018 were analyzed. Percentages of Antibiotic prescriptions by different subgroups and various diagnosis categories and proportions of inappropriate antibiotic prescriptions for different subgroups were estimated. Food and Drug Administration (FDA) pregnancy categories were used to describe the antibiotic prescription patterns. The 95% confidence intervals (CIs) were estimated using the Clopper--Pearson method or Goodman method. RESULTS:Among the 4,574,961 outpatient visits during pregnancy, 2.0% (92,514 visits; 95% CI, 2.0-2.0%) were prescribed at least one antibiotic. The percentage of antibiotic prescriptions for pregnant women aged >40 years was 4.9% (95% CI, 4.7-5.0%), whereas that for pregnant women aged 26-30 years was 1.5% (95% CI, 1.4-1.5%). In addition, percentages of antibiotic prescriptions varied among different trimesters of pregnancy, which were 5.4% (95% CI, 5.3-5.4%) for the visits in the first trimester of pregnancy and 0.5% (95% CI, 0.4-0.5%) in the third trimester of pregnancy. Furthermore, the percentages of antibiotic prescriptions substantially varied among different diagnosis categories and nearly three-quarters of antibiotic prescriptions had no clear indications and thus might be inappropriate. In total, 130,308 individual antibiotics were prescribed; among these, 60.4% (95% CI, 60.0-60.8%) belonged to FDA category B, 2.7% (95% CI, 2.1-3.5%) were classified as FDA category D and 16.8% (95% CI, 16.2-17.4%) were not assigned any FDA pregnancy category. CONCLUSIONS:Antibiotic prescriptions in ambulatory care during pregnancy were not highly prevalent in mainland China. However, a substantial proportion of antibiotics might have been prescribed without adequate indications. Antibiotics whose fetal safety has not been sufficiently illustrated were widely used in pregnant women.
Antibiotic use in endodontic treatment during pregnancy: A narrative review

Tahere Aliabadi,Eshagh Ali Saberi,Amin Motameni Tabatabaei,Ebadolah Tahmasebi

DOI: https://doi.org/10.4081/ejtm.2022.10813

2022-10-20

Abstract:More than half of pregnant women are usually affected by odontogenic pain affects. Pain often accompanies periapical or pulp infections and increases the risks to pregnant patients and their fetuses. The American Dental Association, in partnership with the American College of Obstetricians and Gynecologists, has offered a strong declaration reaffirming the significance of suitable and timely oral health care as an indispensable constituent of a healthy pregnancy. However, there is lack of knowledge about the use of antibiotics in endodontic treatment. Therefore, the present study would review the researches done in this area and tries to provide comprehensive and complete information about the use of antibiotics in endodontic treatment during pregnancy. Based on the results, it can be said that using antibiotics during pregnancy are allowed, and they can be used normally and safely by pregnant women.
Analysis of the Susceptibility to COVID-19 in Pregnancy and Recommendations on Potential Drug Screening.

Xiaoxuan Zhao,Yuepeng Jiang,Yang Zhao,Hongyan Xi,Chang Liu,Fan Qu,Xiaoling Feng

DOI: https://doi.org/10.1007/s10096-020-03897-6

2020-01-01

Abstract:To analyze the susceptibility of SARS-CoV-2 in pregnancy and the drugs that can be used to treat pregnancy with COVID-19, so as to provide evidence for drug selection in clinic. By reviewing the existing literature, this paper analyzes the susceptibility of pregnant women to virus, especially to SARS-CoV-2, from the aspects of anatomical, reproductive endocrine and immune changes during pregnancy and screens effective and fetal-safe treatments from the existing drugs. The anatomical structure of the respiratory system is changed during pregnancy, and the virus transmitted by droplets and aerosols is more easily inhaled by pregnant women and is difficult to remove. Furthermore, the prognosis is worse after infection when compared with non-pregnancy women. And changes in reproductive hormones and immune systems during pregnancy collectively make them more susceptible to certain infections. More importantly, angiotensin-converting enzyme (ACE)-2, the SARS-CoV-2 receptor, has been proven highly increased during pregnancy, which may contribute to the susceptibility to SARS-CoV-2. When it comes to treatment, specific drugs for COVID-19 have not been found at present, and taking old drugs for new use in treating COVID-19 has become an emergency method for the pandemic. Particularly, drugs that show superior maternal and fetal safety are worthy of consideration for pregnant women with COVID-19, such as chloroquine, metformin, statins, lobinavir/ritonavir, glycyrrhizic acid, and nanoparticle-mediated drug delivery (NMDD), etc. Pregnant women are susceptible to COVID-19, and special attention should be paid to the selection of drugs that are both effective for maternal diseases and friendly to the fetus. However, there are still many deficiencies in the study of drug safety during pregnancy, and broad-spectrum, effective and fetal-safe drugs for pregnant women need to be developed so as to cope with more infectious diseases in the future.
Maternal-Fetal Exposure to Antibiotics: Levels, Mother-to-Child Transmission, and Potential Health Risks

Shiyu Miao,Jia Yin,Shuang Liu,Qingqing Zhu,Chunyang Liao,Guibin Jiang

DOI: https://doi.org/10.1021/acs.est.4c02018

IF: 11.4

2024-05-05

Environmental Science & Technology

Abstract:Due to its widespread applications in various fields, antibiotics are continuously released into the environment and ultimately enter the human body through diverse routes. Meanwhile, the unreasonable use of antibiotics can also lead to a series of adverse outcomes. Pregnant women and developing fetuses are more susceptible to the influence of external chemicals than adults. The evaluation of antibiotic exposure levels through questionnaire surveys or prescriptions in medical records and...

environmental sciences,engineering, environmental
Anti‐Infective Dosing in Special Populations: Pregnancy

Phoebe Hazenberg,Kate Navaratnam,Paula Busuulwa,Catriona Waitt

DOI: https://doi.org/10.1002/cpt.2192

2021-03-10

Abstract:Substantial anatomical and physiological changes occur during pregnancy and labor, which impact on drug absorption, distribution, metabolism, and elimination. Reduced maternal concentrations may have a clinically important impact on the efficacy of anti-infectives for mother, fetus, and neonate, with potential dosing implications. However, there is a paucity of pregnancy-specific data examining this. Existing data on the pharmacokinetics of anti-infectives in pregnancy are summarized and evaluated, with emphasis on agents that are used in treatment of HIV, tuberculosis, malaria, and common bacterial infections. Limitations and challenges in achieving ideal study designs in pregnant populations are highlighted, and key quality considerations for the generation of the highest quality evidence are outlined. PubMed was searched for each chosen anti-infective. Pharmacokinetic studies which either compared pharmacokinetics from pregnant women against nonpregnant controls, or which assessed concentrations against a known minimum inhibitory concentration were included. Two independent reviewers extracted data from each study and appraised them using the 24-point ClinPK Checklist. The main finding was that there is a lack of published data for anti-infectives in pregnancy, despite their clinical importance. Of the studies identified, only those investigating cobicistat-boosted antiretroviral regimens firmly concluded that these should not be used in pregnancy. Most studies concluded either that further research was needed, or that there were significant pharmacokinetic differences between pregnant and nonpregnant participants which had uncertain clinical significance. Challenges in applying existing quality grading systems to these studies were noted, suggesting a development of a refined system for appraisal of pharmacokinetic studies in "special populations" may be warranted.

pharmacology & pharmacy
BACTERIA ASSOCIATED WITH URINARY TRACT INFECTION IN PREGNANT WOMEN WITH OVERVIEW OF THEIR ANTIBIOTIC SUSCEPTIBILITY TESTS

BHOOMIKA RAVI,TALLURI RAMESHWARI K. R.,SUMANA K.

DOI: https://doi.org/10.22159/ijcpr.2022v14i4.2007

2022-07-15

International Journal of Current Pharmaceutical Research

Abstract:Urinary tract infection (UTI) is one of the most common health problems among pregnant women and the reason for morbidity during pregnancy in worldwide, most of them in developing countries. The causative agents include Escherichia coli, Klebsiella species, Staphylococcus aureus, Staphylococci, Proteusmirabilis, Enterococcus species, Pseudomonas aeruginosa, Enterobacter species, streptococci, and Citrobacter species. Risk factors in pregnant women is more in urinary tract infection (UTI). This current research aimed that which drug is resistance for pathogenic bacteria and their resistance gene patterns in pregnant women. The altogether predominance of urinary tract infections in pregnant women is approximately 13-18% overall. Gram-positive and gram-negative both bacteria were isolated. Which shows gram-negative bacteria (85%) and gram-positive bacteria were only 15%. E. coliis the most predominant bacteria among the study. And the antimicrobial susceptibility patters of these isolates showed high resistance towards nitrofurantoin, ciprofloxacin, and gentamycin. More sensitive towards amoxiclav, cefuroxime, etc., Pregnant women with Asymptomatic UTI consider E. coli, Klebsiella pneumonia, Proteus mirabilis, Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus arlettae, Enterococcus faecalis and showed resistance to most drugs. The frequent appearance of isolates from urine sample along with their resistance capability tests. The antibiotics can be prescribed based on side effect to prevent pregnant women in case of empirical treatment. In order to overcome the problem of UTI in pregnant women many researches are going on, currently, the drug resistant of UTI is leading to the new technologies and identification method of drug-resistant UTI helps to overcome the infection.
Antibiotic Treatments to Mothers During the Perinatal Period Leaving Hidden Trouble on Infants

Ji Chenyang,Zhang Geer,Xu Siyuan,Xiang Qingyi,Huang Meishuang,Zhao Meirong,Bai Xiaoxia

DOI: https://doi.org/10.1007/s00431-022-04516-6

2022-01-01

European Journal of Pediatrics

Abstract:Antibiotic application during the perinatal period is unavoidable in the clinic, but the potential effects on mothers and infants remain unknown. Herein, 25 breast milk samples from mothers who received cefuroxime (CXM) or CXM + cefoxitin (CFX) treatments and fecal samples from their infants were collected to investigate the undesirable effects of antibiotics on the microbiota of mothers and neonates. Furthermore, five fecal samples of infants, whose mothers had antibiotic treatments, were collected at a 6-month postpartum follow-up visit to evaluate the long-term effects on infants’ gut microbiota. Moreover, the relative abundance of antibiotic resistance genes (ARGs) in fecal samples was compared to investigate the transfer of ARGs in the infant gut microbiota. The results indicated that the antibiotic treatments had no influence on the microbiota of breast milk. The dominant bacterial phyla in the fecal samples changed to Firmicutes and Proteobacteria after antibiotic treatments, while the bacterial community showed a recuperative trend at the follow-up visits. In addition, the abundance of ARGs in the infant gut microbiota demonstrated a declining trend in the CXM- and CXM + CFX-treated groups, while ARG abundance presented a significant increasing trend after a 6-month recovery period. Conclusion: Antibiotic treatments for mothers during the perinatal period disturb the gut microbiota in neonates. The infants’ gut microbiota would partly return to their initial state after rehabilitation, but the transfer of ARGs would leave the hidden trouble of antibiotic resistance. Overall, the data presented here can help to guide the scientific use of antibiotics during the perinatal period and provide potential approaches to mitigate the negative consequences.
[Optimization of antibiotic therapy in pregnancy--clinical implications]

Edyta Szałek,Hanna Tomczak,Agnieszka Seremak-Mrozikiewicz,Joanna Bartkowiak-Wieczorek,Edmund Grześkowiak

Abstract:The aim of the antibacterial therapy during pregnancy is to select a proper antibiotic and determine its effective dose, at the same time excluding the risk of potential teratogenic effect. Pregnancy is characterized by many physiological, disease-predisposing changes, particularly of bacterial etiology that have an influence on different pharmacokinetic of drugs. When determining an effective dose of an antibiotic, one should take into account changes in the pharmacokinetics (PK) of drugs in pregnant women, involving mainly the phase of distribution (increased volume of body fluids, cardiac output, reduced concentration of albumins), metabolism (induction of hepatic enzymes: CYP3A4, CYP2D6, CYP2C9, UGT1A4, UGT2B7, inhibition of CYP1A2, CYP2C19), and excretion (increased glomerular filtration rate). Results of few pharmacokinetic studies on pregnant patients point to the need of increasing the dose or reducing dosage intervals for some antibiotics (e.g. penicillin V ampicillin, piperacillin, imipenem, clindamycin). The aim of this study was to summarize current knowledge regarding the PK of antibiotics during pregnancy.
Antibiotic Use During Pregnancy and Childbirth: Prospective Observational Study on Prevalence, Indications, and Prescribing Patterns in a German Tertiary Center

Anna-Lara Schilling,Achim Rody,Verena Bossung

DOI: https://doi.org/10.1055/a-1934-1761

2022-12-04

Geburtshilfe und Frauenheilkunde

Abstract:Introduction Antibiotics are powerful drugs to prevent and treat perinatal infections. Overuse of antibiotics leads to antibiotic resistance, has potential side effects and influences the maternal and neonatal microbiome. Patients and Methods We performed a prospective observational study on the prevalence, indications, and prescribing patterns of antibiotics during pregnancy and childbirth. We included women who had given birth after 23+0 weeks of gestation at a single tertiary center in Germany from January 2020 to March 2021. Descriptive statistics and binomial regression were performed to analyze the factors influencing the prescription of antibiotics. Results We included 522 postpartum women into our study. 337 (64.6%) were exposed to antibiotics during pregnancy and/or childbirth. 115 women received antibiotics during pregnancy, 291 during birth. Most antibiotics during pregnancy were prescribed for urinary tract infections (UTIs) (56.0%). Most prescriptions were issued by obstetrics and gynecology physicians (65.8%), followed by hospitals (16.7%) and family medicine physicians (8.8%). Most antibiotics during childbirth were given for a cesarean section (64.3%), followed by preterm rupture of membranes (41.2%). 95.3% of women who had a preterm birth were exposed to antibiotics. In logistic regression models, lower gestational age at birth, higher maternal body-mass-index and smoking were independently associated with antibiotic use during pregnancy and childbirth. Conclusion We found a high rate of antibiotic exposure during pregnancy and childbirth. Our results imply an urgent need for antibiotic stewardship programs in perinatal medicine as well as further research on the effects of perinatal antibiotic exposure on microbiome development and childhood health. Einleitung Antibiotika sind potente Medikamente, die verschrieben werden, um perinatale Infektionen zu verhindern oder zu behandeln. Der übermäßige Einsatz von Antibiotika führt zur Antibiotikaresistenz, ist potenziell mit Nebenwirkungen behaftet und hat zudem Auswirkungen auf das mütterliche und neonatale Mikrobiom. Patientinnen und Methoden Wir führten eine prospektive Beobachtungsstudie durch, um die Prävalenz, die Indikationen und die Verschreibungsmuster für Antibiotika während der Schwangerschaft und der Geburt zu untersuchen. Eingeschlossen wurden Frauen, die nach 23+0 Schwangerschaftswochen zwischen Januar 2020 and März 2021 in einem deutschen universitären Perinatalzentrum Level I entbanden. Es wurden eine deskriptive statistische Analyse sowie binomiale Regressionsanalysen durchgeführt, um Faktoren, welche die Verschreibung von Antibiotika beeinflussen, zu identifizieren. Ergebnisse Insgesamt wurden 522 Frauen nach der Entbindung eingeschlossen. 337 (64,6%) erhielten Antibiotika während der Schwangerschaft und/oder der Geburt. 115 Frauen erhielten Antibiotika während der Schwangerschaft und 291 Frauen erhielten sie während der Geburt. Die meisten Antibiotika wurden während der Schwangerschaft zur Behandlung von Harnwegsinfektionen verschrieben (56,0%). Die meisten Verschreibungen wurden von Frauenärzten ausgestellt (65,8%), gefolgt von Krankenhäusern (16,7%) und Hausärzten (8,8%). Die meisten während der Geburt verabreichten Antibiotika wurden wegen eines Kaiserschnitts (64,3%) verschrieben; an zweiter Stelle war die Verschreibung wegen vorzeitigen Blasensprungs (41,2%). 95,3% der Frauen, die eine Frühgeburt hatten, wurden mit Antibiotika behandelt. In den Regressionsmodellen war ein niedriges Gestationsalter bei der Entbindung, ein hoher mütterlicher Body-Mass-Index und Rauchen unabhängig voneinander mit dem Einsatz von Antibiotika während der Schwangerschaft und der Geburt assoziiert. Schlussfolgerung Unsere Studie zeigt eine hohe Antibiotikaexposition von Frauen während Schwangerschaft und Geburt. Die Ergebnisse weisen darauf hin, dass ein Antibiotic-Stewardship-Programm in der Perinatalmedizin dringend nötig ist. Weitere Studien zu den Auswirkungen einer perinatalen Antibiotikaexposition auf die frühe Entwicklung des menschlichen Mikrobioms sowie auf die Gesundheit von Kindern werden benötigt. Received: 19 June 2022 Accepted after revision: 28 August 2022 Article published online: 02 December 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may -Abstract Truncated-

obstetrics & gynecology
An Investigation and Analysis of Antibiotic Usage in Department of Obstetrics and Gynecology

HUANG Li-ping,WU Wei

DOI: https://doi.org/10.3969/j.issn.1007-1237.2007.04.012

2007-01-01

Abstract:Objective: To evaluate the usage of antibiotics and to enhance the rationality of antibiotics usage in department of Obstetrics and Gynecology.Methods: cluster sampling was introduced and the usage of antibiotics was investigated retrospectively from Jan 2004 to Dec 2006.Results: 5817 medical records were surveyed,the percentage of antibiotics usage is 44.15% and preventive use took up 93.73%.Conclusion: We should pay more attention to the management of antibiotics usage and elevate the reasonable application of antibiotics in clinic.
Urinary antibiotic exposure across pregnancy from Chinese pregnant women and health risk assessment: Repeated measures analysis

Menglong Geng,Kaiyong Liu,Kun Huang,Yitian Zhu,Peng Ding,Jingjing Zhang,Baolin Wang,Wenwen Liu,Yan Han,Hui Gao,Sheng Wang,Guanjun Chen,Xiaoyan Wu,Fangbiao Tao

DOI: https://doi.org/10.1016/j.envint.2020.106164

Abstract:Multiple antibiotics are widely used in clinic practice and livestock husbandry, but exposure data based on repeated measurements are scarce among pregnant women. Here, we biomonitored 41 antibiotics and their two metabolites in urine samples from 3235 pregnant women over three trimesters. Spearman's correlation coefficient, intraclass correlation coefficient (ICC), percentile analysis and linear mixed models were employed to evaluate the correlations, variability, co-exposure patterns and predictors of antibiotics, respectively. Pregnant urinary creatinine-adjusted concentrations of antibiotics were used to estimate daily exposure dose and assessed health risks. The target antibiotics were detected in more than 90% of urine samples, primarily as preferred as veterinary antibiotics (PVAs), and the 95th percentile urinary concentrations of each individual antibiotics were range from below the limits of detection to 5.74 ng/mL. We observed considerable within-subject variation (ICC: 0.05-0.63) of urinary antibiotics concentrations during pregnancy. More than half pregnant women were co-exposed to two or more antibiotics of different usage classes, while both co-exposure to high percentiles of three usage antibiotics at one trimester or exposure to single usage antibiotics at high-dose through three trimesters were infrequent in the study population, and most pregnant women were continuously exposed to low-dose PVAs across pregnancy. A total of 4.5% samples were showed hazard index values exceeding 1 during entire pregnancy. Urinary levels of antibiotics associated with residence, maternal age and education, pre-pregnancy BMI, household income and gestational week, especially vary by sampling seasons. Taken together, most pregnant women were frequently exposure to low-dose PVAs across pregnancy and some were in a health risk associated with the disturbance of gut microbiota. Multiple measurements of urinary antibiotic concentrations are essential to more accurate charactering the exposure levels during pregnancy. Several predictors of urinary antibiotics should be taken into consideration in future researches.
Diagnosis and Treatment of Pregnancy with Infectious Disease

XU Feng,FENG Ze-jiao,CHEN Wen-shu

2013-01-01

Abstract:Objective To study the diagnosis and treatment of pregnancy with infectious diseases.Methods All 172 cases of pregnancy with infectious diseases and receiving antibiotic therapy were enrolled into observation group and 68 cases with untreated infectious diseases were enrolled into control group.The maternal pregnancy outcomes including premature rupture of membranes,preterm labor,low birth weight,neonatal asphyxia,perinatal mortality and incidence rate of cesarean section were recorded.Newborns were followed up for 1 year,the incidence of congenital syphilis and wart infection was recorded.Results The early treatment in observation group improved the neonatal survival rate,reduced the incidence of premature delivery and stillbirth,decrease the possibility of neonatal congenital infection(P < 0.05).The early treatment also reduced the number of low birth weight infants,decreased the rate of cesarean section and the possibilities of neonatal congenital infections(P < 0.05).Conclusion The early diagnosis and treatment of infectious diseases can effectively improve the neonatal survival rate and reduce the numbers of afflicted children.

Antibiotic use in pregnancy and lactation

Antibiotic Therapy in Pregnancy and Lactation

Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration

Antibiotics and Other Anti-infective Agents in Pregnancy and Lactation

Antibiotic use in pregnancy

ANTIBACTERIAL AGENTS IN PREGNANCY

Use of Anti-Infective Agents During Lactation: Part 1—Beta-Lactam Antibiotics, Vancomycin, Quinupristin-Dalfopristin, and Linezolid

Safety of Anti-hepatitis B Virus Therapy During Pregnancy and Lactation

Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation

Antibiotic Prescriptions among China Ambulatory Care Visits of Pregnant Women: A Nationwide Cross-Sectional Study.

Antibiotic use in endodontic treatment during pregnancy: A narrative review

Analysis of the Susceptibility to COVID-19 in Pregnancy and Recommendations on Potential Drug Screening.

Maternal-Fetal Exposure to Antibiotics: Levels, Mother-to-Child Transmission, and Potential Health Risks

Anti‐Infective Dosing in Special Populations: Pregnancy

BACTERIA ASSOCIATED WITH URINARY TRACT INFECTION IN PREGNANT WOMEN WITH OVERVIEW OF THEIR ANTIBIOTIC SUSCEPTIBILITY TESTS

Antibiotic Treatments to Mothers During the Perinatal Period Leaving Hidden Trouble on Infants

[Optimization of antibiotic therapy in pregnancy--clinical implications]

Antibiotic Use During Pregnancy and Childbirth: Prospective Observational Study on Prevalence, Indications, and Prescribing Patterns in a German Tertiary Center

An Investigation and Analysis of Antibiotic Usage in Department of Obstetrics and Gynecology

Urinary antibiotic exposure across pregnancy from Chinese pregnant women and health risk assessment: Repeated measures analysis

Diagnosis and Treatment of Pregnancy with Infectious Disease